Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6975 USD | -3.87% | -7.00% | -76.19% |
Mar. 15 | North American Morning Briefing : Inflation -2- | DJ |
Mar. 14 | Top Midday Decliners | MT |
Financials (USD)
Sales 2024 * | 6.65M | Sales 2025 * | 1.67M | Capitalization | 28.71M |
---|---|---|---|---|---|
Net income 2024 * | -50M | Net income 2025 * | -56M | EV / Sales 2024 * | -2.31 x |
Net cash position 2024 * | 44.1M | Net cash position 2025 * | 89.5M | EV / Sales 2025 * | -36.4 x |
P/E ratio 2024 * |
-0.57
x | P/E ratio 2025 * |
-0.7
x | Employees | 22 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 92.25% |
Latest transcript on Spruce Biosciences, Inc.
1 day | -3.87% | ||
1 week | -7.00% | ||
Current month | -1.48% | ||
1 month | -0.61% | ||
3 months | -87.30% | ||
6 months | -50.88% | ||
Current year | -76.19% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 22-01-02 | |
Samir Gharib
DFI | Director of Finance/CFO | 41 | 20-04-30 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dan Spiegelman
BRD | Director/Board Member | 65 | 20-09-08 |
Michael Grey
CHM | Chairman | 71 | 17-03-31 |
Tiba Aynechi
BRD | Director/Board Member | 48 | 16-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.6975 | -3.87% | 485,358 |
24-05-23 | 0.7256 | -3.40% | 705,031 |
24-05-22 | 0.7511 | -2.06% | 162,487 |
24-05-21 | 0.7669 | +1.83% | 259,623 |
24-05-20 | 0.7531 | +0.41% | 420,240 |
Delayed Quote Nasdaq, May 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-76.19% | 28.71M | |
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+45.66% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- SPRB Stock